Wolverine Trading’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.56M | Sell |
89,500
-7,900
| -8% | -$525K | ﹤0.01% | 1196 |
|
|
2025
Q2 | $5.09M | Buy |
97,400
+59,500
| +157% | +$3.39M | 0.01% | 1049 |
|
|
2025
Q1 | $2.42M | Sell |
37,900
-2,500
| -6% | -$145K | ﹤0.01% | 1472 |
|
|
2024
Q4 | $1.94M | Buy |
40,400
+25,100
| +164% | +$1.29M | ﹤0.01% | 1987 |
|
|
2024
Q3 | $872K | Buy |
15,300
+9,300
| +155% | +$533K | ﹤0.01% | 2495 |
|
|
2024
Q2 | $314K | Sell |
6,000
-1,800
| -23% | -$78.9K | ﹤0.01% | 3337 |
|
|
2024
Q1 | $317K | Sell |
7,800
-3,800
| -33% | -$142K | ﹤0.01% | 3293 |
|
|
2023
Q4 | $429K | Buy |
11,600
+3,300
| +40% | +$124K | ﹤0.01% | 3114 |
|
|
2023
Q3 | $317K | Buy |
+8,300
| New | +$340K | ﹤0.01% | 3232 |
|
|
2023
Q2 | – | Sell |
-14,700
| Closed | -$548K | – | 4520 |
|
|
2023
Q1 | $548K | Buy |
+14,700
| New | +$690K | ﹤0.01% | 2415 |
|
|
2022
Q1 | – | Sell |
-8,200
| Closed | -$331K | – | 5799 |
|
|
2021
Q4 | $331K | Buy |
+8,200
| New | +$306K | ﹤0.01% | 4014 |
|
|
2021
Q3 | – | Sell |
-6,900
| Closed | -$316K | – | 6520 |
|
|
2021
Q2 | $316K | Buy |
+6,900
| New | +$305K | ﹤0.01% | 4361 |
|
|
2020
Q4 | – | Sell |
-14,600
| Closed | -$387K | – | 5052 |
|
|
2020
Q3 | $387K | Sell |
14,600
-300
| -2% | -$8.35K | ﹤0.01% | 3090 |
|
|
2020
Q2 | $385K | Sell |
14,900
-500
| -3% | -$11.3K | ﹤0.01% | 3035 |
|
|
2020
Q1 | $280K | Buy |
15,400
+1,600
| +12% | +$30.4K | ﹤0.01% | 3299 |
|
|
2019
Q4 | $246K | Buy |
13,800
+3,100
| +29% | +$53.7K | ﹤0.01% | 3826 |
|
|
2019
Q3 | $163K | Buy |
+10,700
| New | +$176K | ﹤0.01% | 3678 |
|
|
2019
Q2 | – | Sell |
-11,300
| Closed | -$182K | – | 4696 |
|
|
2019
Q1 | $182K | Sell |
11,300
-8,700
| -44% | -$141K | ﹤0.01% | 3890 |
|
|
2018
Q4 | $286K | Sell |
20,000
-1,900
| -9% | -$30.3K | ﹤0.01% | 3252 |
|
|
2018
Q3 | $398K | Sell |
21,900
-24,000
| -52% | -$420K | ﹤0.01% | 3392 |
|
|
2018
Q2 | $899K | Hold |
45,900
| – | – | ﹤0.01% | 2373 |
|
|
2018
Q1 | $899K | Sell |
45,900
-45,400
| -50% | -$879K | ﹤0.01% | 2373 |
|
|
2017
Q4 | $1.85M | Buy |
91,300
+57,000
| +166% | +$1.05M | 0.01% | 1618 |
|
|
2017
Q3 | $596K | Sell |
34,300
-14,800
| -30% | -$200K | ﹤0.01% | 2428 |
|
|
2017
Q2 | $637K | Sell |
49,100
-26,100
| -35% | -$349K | ﹤0.01% | 2190 |
|
|
2017
Q1 | $980K | Buy |
+75,200
| New | +$951K | 0.01% | 1732 |
|
|
2016
Q3 | – | Sell |
-53,900
| Closed | -$454K | – | 4776 |
|
|
2016
Q2 | $454K | Buy |
+53,900
| New | +$532K | ﹤0.01% | 2313 |
|
Other funds holding HALO
SCM
Wolverine Trading's HALO Position: Q3 2025 in Review
Wolverine Trading reduced its Halozyme (HALO) stake by 21% in Q3 2025, selling an estimated $671K and leaving 37,929 shares worth $2.78M. The position accounts for ﹤0.01% of the portfolio, ranked #1887.
Wolverine Trading first reported a position in HALO in Q1 2017 and has held it in 18 quarters since. 602 funds tracked by Wall St. Rank hold HALO as of Q3 2025.
- Wolverine Trading held 37,929 shares of Halozyme worth $2.78M as of Q3 2025.
- Wolverine Trading sold 10,101 Halozyme shares in Q3 2025, an estimated $671K.
- Halozyme made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #1887 holding.
- Wolverine Trading first reported a position in Halozyme in Q1 2017 and has held it in 18 quarters since.
- 602 funds tracked by Wall St. Rank held Halozyme as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.